BBNX — Beta Bionics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Beta Bionics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27.7	96.7	104
Net Total Accounts Receivable
Net Total Receivables	0	4.45	12
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28.5	104	133
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.87	6.2	11.4
Other Long Term Assets
Total Assets	35.5	110	150
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.87	10.6	21.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.5	51.4	73.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	13	58.6	76
Total Liabilities & Shareholders' Equity	35.5	110	150
Total Common Shares Outstanding